Neuromed Pharmaceuticals

Provider of calcium channel blockers for pain treatment

placeVancouver, British Columbia, Canada calendar_todayFounded 1998 language neuromed.com

Innovation

32 patent families (14 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace dormant. Cited 1,252 times.

YearFilings
20122
20131
20151

Investor mix

5 investors on record; lead investors include GrowthWorks Capital, BDC, Royal Bank of Canada, MDS Capital.

Investor typeCountShare
Venture capital240%
Angel & family office120%
Other / undisclosed240%
Coming soon